| Strategy/Fund | Net Asset Value ($ millions) |
| Common Investment Fund | 4,054.0 |
| Global Equities | 1,383.4 |
| BNY Stock Index | 363.8 |
| DSM | 276.7 |
| GMO | 368.5 |
| Newton DUSE | 374.4 |
| Emerging Markets Equities | 50.7 |
| Acadian | 50.7 |
| Fixed Income | 192.9 |
| CASH | 192.9 |
| Hedge Funds | 880.7 |
| Acasta | 53.7 |
| Anchorage | 9.8 |
| BlackRock Emerging Companies | 65.1 |
| BlackRock Strategic | 96.8 |
| BlackRock Systematic China Absolute Return | 56.2 |
| Camber | 21.3 |
| Drake Funds | 86.1 |
| Elliott Intl | 91.7 |
| Indaba | 12.7 |
| Lithic | 48.5 |
| Oculus Intn | 13.8 |
| Samlyn Net Neutral | 77.9 |
| TAL China | 19.4 |
| The Obsidian Offshore | 27.9 |
| Theorem | 56.2 |
| Two Sigma AR Enhanced | 31.4 |
| Viking | 109.8 |
| Other | 2.4 |
| Private Investments | 1,330.6 |
| ABRY Adv Sec II | .1 |
| ABRY Adv Sec III | 6.3 |
| ABRY SR Eq. V | 5.4 |
| ABRY Sr. Eq. IV | .6 |
| ABRY VII | .6 |
| ABRY VIII | .9 |
| Advent GPE X | 4.4 |
| Advent Intl IX | 25.9 |
| Advent Intl VII | 1.3 |
| Advent Intl VIII | 20.6 |
| Alkali International IV | 12.7 |
| Alkali International V | 10.5 |
| American Sec. VII | 20.0 |
| Arboretum IV | 3.2 |
| Artiman 2014 | 13.7 |
| Artiman III | 2.5 |
| Artiman Select 2014 | 2.2 |
| ASF VI | 3.5 |
| ASF VII | 14.3 |
| Atlas Capital II | 8.9 |
| Axiom Asia III | 6.8 |
| Axiom Asia IV | 34.7 |
| Axiom Asia Opportunity | 8.4 |
| Axiom Asia V | 20.9 |
| Axiom Asia VI | 11.3 |
| Bain X | 2.6 |
| Blue Point IV | 19.4 |
| Brazos III | .3 |
| BSCH II | 9.8 |
| BXHCP ES II, LLC | 1.9 |
| BXHCP ES III | 1.0 |
| CA Bain Europe III | .3 |
| Castlelake IV | 8.9 |
| CB Offshore Equity Fund X. LP | 7.6 |
| Centerbridge Capital | .4 |
| Cerberus 4 | .1 |
| CF Venture VII | .9 |
| Charlesbank IX | 19.5 |
| Charlesbank VIII | 5.7 |
| Columbia IV | .6 |
| Deerfield Design III | 10.6 |
| Deerfield Design IV | 29.6 |
| Dover IX | 15.2 |
| Dover VIII | 1.0 |
| Elliott B-1 L.P. | 9.8 |
| Elliott CIC2 - B-1 | 8.9 |
| Flagship Pioneering Fund VII | 9.1 |
| Flagship Special Opportunities Fund II | 19.7 |
| Fortress Credit Opp III | .6 |
| Fortress Credit Opp IV | 7.3 |
| Fortress Credit Opp V | 13.0 |
| Foundation Capital Leadership II | 11.3 |
| Foundation Capital Leadership III | 5.2 |
| Foundation IX | 15.3 |
| Foundation VIII | 35.0 |
| Foundation X | 8.4 |
| Francisco III | 1.7 |
| Francisco IV | 8.4 |
| GGV IV | .7 |
| GGV Select | 8.2 |
| GGV V | 11.4 |
| GGV VI | 11.9 |
| GGV VI Plus | 2.7 |
| Granite II | 3.4 |
| Great Hill IV | 4.0 |
| Great Hill V | 9.7 |
| Great Hill VII | 9.9 |
| Great Hill VIII | 3.3 |
| GTCR XI A | 16.6 |
| InterWest X | 1.9 |
| J.H. Whitney VII | 3.8 |
| JMI VII | .7 |
| JMI VIII | 6.5 |
| Kelso VIII | .3 |
| Lightspeed IX | 22.9 |
| Lightspeed Select | 7.4 |
| Lightspeed Select II | 15.0 |
| Lightspeed X | 25.1 |
| Lightspeed XI | 18.7 |
| Littlejohn Fund V | 9.9 |
| Littlejohn Opportunities II | 21.1 |
| Madison Dearborn V | .2 |
| Mangrove II | 1.0 |
| Meritech IV | .7 |
| Meritech V | 5.9 |
| Meritech V Sidecar | 2.8 |
| Meritech VI | 10.2 |
| Multi-Alt Opps | 16.5 |
| Olympus VI | 14.7 |
| Olympus VII | 35.0 |
| Operator Collective | 14.7 |
| Operator Collective II | 2.2 |
| OrbiMed Asia IV | 7.0 |
| OrbiMed Asia V | .4 |
| OrbiMed IX | 1.1 |
| OrbiMed Royalty II | .7 |
| OrbiMed V | 2.4 |
| OrbiMed VI | 9.3 |
| OrbiMed VII | 32.3 |
| OrbiMed VIII | 13.7 |
| Park St PE VII | .2 |
| Pear Ventures IV | .9 |
| Petershill IV Offshore | 5.7 |
| Providence VI | .1 |
| Rho VI | 1.9 |
| Sentinel V | .9 |
| Sigma IX | 4.4 |
| Strategic IX | 11.9 |
| Strategic VI | 4.4 |
| Strategic VII | 18.5 |
| Strategic VIII | 35.0 |
| SV Life Sciences V | 1.4 |
| SV Life Sciences VI | 8.7 |
| TA XI | .9 |
| TA XII-A | 26.9 |
| TA XIII-B | 19.3 |
| TA XIV-B | 12.2 |
| Telegraph Hill III | 7.4 |
| Thoma Bravo Discover | 3.2 |
| Thoma Bravo Sp Opp II | 3.3 |
| Thoma Bravo X | 2.9 |
| Thoma Bravo XI | 14.2 |
| Thoma Bravo XII | 16.2 |
| Thompson St IV | 21.5 |
| Thompson St V | 14.8 |
| TI Platform Fund III | 3.0 |
| Trident IX | 6.3 |
| Trident VI | 10.7 |
| Trident VII | 42.1 |
| TrueBridge | 22.7 |
| Truebridge II | 13.2 |
| Truebridge III | 5.0 |
| Two Sigma III | 8.5 |
| Two Sigma IV | 2.2 |
| U.S.V.P. X | 1.3 |
| Upfront Growth II | 4.7 |
| Upfront Growth III | 4.3 |
| Upfront VI | 17.8 |
| Upfront VII | 4.7 |
| Varde X | .2 |
| Vintage IX | .7 |
| VIP II B | 6.1 |
| VIP II B SF | .8 |
| WndrCo | 25.5 |
| Private Real Assets | 120.3 |
| ArcLight Energy VI | 6.1 |
| Denham Commodity VI | 4.2 |
| EnCap Flatrock Midst II | .6 |
| EnCap Flatrock Midst III | 6.8 |
| EnCap Flatrock Midst IV | 6.3 |
| EnCap IX | 2.5 |
| EnCap VIII | 1.9 |
| EnCap X | 10.9 |
| EnerVest XIV | 7.7 |
| Lime Rock Partners IV AF, L.P. | 29.0 |
| Lime Rock Res. II-C | .1 |
| Lime Rock Res. III-C | 6.3 |
| Lime Rock V | .7 |
| LS Power III | 17.1 |
| Park St NRF II | .1 |
| Resource Capital IV | .7 |
| Resource Capital V | .2 |
| Resource Capital VI | 6.0 |
| Trace Energy Resources | 13.1 |
| Private Real Estate | 95.5 |
| Blackstone RE Europe V | 8.9 |
| Blackstone RE IX | 26.7 |
| Blackstone RE VI | .1 |
| Blackstone RE VII | .9 |
| Blackstone RE VIII | 11.4 |
| CrossHarbor 2014 | .7 |
| Lone Star RE III | .1 |
| Lone Star RE IV | 3.1 |
| Lone Star RE V | 1.5 |
| Orion III | .7 |
| Orion IV | 3.1 |
| Platform - Fisher | 21.3 |
| Platform - Piquette | 6.4 |
| SSC IV | .4 |
| SSC V | 4.4 |
| Westbrook RE IX | .9 |
| Westbrook RE X | 5.0 |